However, CD97 mRNA expression levels were not affected by TCFs, as determined in inducible dominant-negative TCF colorectal tumor cell lines, and co-expression of WT or S33A-mutated β-catenin with TCF-4 did not enhance CD97 promoter activity (26). The gene discussed is ADGRE5; the disease is colorectal neoplasm.